Challenges in maintaining medicine quality while aiming for universal health coverage: a qualitative analysis from Indonesia

A Hasnida, MO Kok, E Pisani - BMJ global health, 2021 - gh.bmj.com
Introduction Indonesia, the world's fourth most populous nation, is close to achieving
universal health coverage (UHC). A widely-publicised falsified vaccine case in 2016 …

Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO

T Piggott, A Nowak, R Brignardello-Petersen… - BMJ open, 2022 - bmjopen.bmj.com
Objectives Examining the availability of essential medicines is a necessary step to monitor
country-level progress towards universal health coverage. We compared the 2017 essential …

[HTML][HTML] The impact of pharmaceutical tendering on prices and market concentration in South Africa over a 14-year period

OJ Wouters, DM Sandberg, A Pillay… - Social science & …, 2019 - Elsevier
Abstract Objective We investigated the South African tendering system for medicines to (a)
evaluate its impact on prices and market concentration over a 14-year period and (b) …

[HTML][HTML] Medicine in motion: Opportunities, challenges and data analytics-based solutions for traditional medicine integration into western medical practice

C Jansen, JD Baker, E Kodaira, L Ang… - Journal of …, 2021 - Elsevier
Ethnopharmacological relevance Traditional pharmacopeias have been developed by
multiple cultures and evaluated for efficacy and safety through both historical/empirical …

The elimination of human African trypanosomiasis is in sight: Report from the third WHO stakeholders meeting on elimination of gambiense human African …

MP Barrett - PLoS neglected tropical diseases, 2018 - journals.plos.org
In 2012, the World Health Organisation (WHO) set out a roadmap for the control, elimination,
or eradication of 17 neglected tropical diseases by 2020 [1]. Many were skeptical about the …

Availability, pricing and affordability of essential medicines in Eastern Ethiopia: a comprehensive analysis using WHO/HAI methodology

M Sisay, F Amare, B Hagos… - Journal of Pharmaceutical …, 2021 - Taylor & Francis
Background Access to essential medicines is a universal human right and availability and
affordability are the preconditions for it. In line with the sustainable development goals …

[HTML][HTML] Effect of Novartis Access on availability and price of non-communicable disease medicines in Kenya: a cluster-randomised controlled trial

PC Rockers, RO Laing, PG Ashigbie… - The Lancet Global …, 2019 - thelancet.com
Summary Background Novartis Access is a Novartis programme that offers a portfolio of non-
communicable disease medicines at a wholesale price of US $1 per treatment per month in …

[HTML][HTML] Medicine procurement and the use of flexibilities in the Agreement on Trade-Related Aspects of Intellectual Property Rights, 2001–2016

E FM't Hoen, J Veraldi, B Toebes… - Bulletin of the World …, 2018 - ncbi.nlm.nih.gov
Millions of people, particularly in low-and middle-income countries, lack access to effective
pharmaceuticals, often because they are unaffordable. The 2001 Ministerial Conference of …

Barriers and facilitators to implementation of cancer treatment and palliative care strategies in low-and middle-income countries: systematic review

A Donkor, T Luckett, S Aranda, J Phillips - International journal of public …, 2018 - Springer
Objectives To appraise improvement strategies adopted by low-and middle-income
countries to increase access to cancer treatments and palliative care; and identify the …

Service readiness for noncommunicable diseases was low in five countries in 2013–15

C Moucheraud - Health Affairs, 2018 - healthaffairs.org
The growing burden of noncommunicable diseases (NCDs) may pose challenges for
resource-limited health systems. This study used standardized, nationally representative …